DYADIC INTERNATIONAL INC Weighted Average Number of Shares Issued, Basic
DYADIC INTERNATIONAL INC (DYAI) reported Weighted Average Number of Shares Issued, Basic of 36.44 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesIssuedBasic · last filed 2026-08-12
- DYADIC INTERNATIONAL INC weighted average number of shares issued, basic for the quarter ending 2026-06-30 was 36.44M shares, a 21.05% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares issued, basic for the quarter ending 2026-03-31 was 36.40M shares, a 21.79% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares issued, basic for the quarter ending 2025-09-30 was 34.51M shares, a 16.96% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares issued, basic for the quarter ending 2025-06-30 was 30.10M shares, a 2.77% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares issued, basic for fiscal 2025 was 32.62M shares, a 11.28% increase from fiscal 2024.
- DYADIC INTERNATIONAL INC weighted average number of shares issued, basic for fiscal 2024 was 29.32M shares, a 1.80% increase from fiscal 2023.
- DYADIC INTERNATIONAL INC weighted average number of shares issued, basic for fiscal 2023 was 28.80M shares, a 1.53% increase from fiscal 2022.
- DYADIC INTERNATIONAL INC weighted average number of shares issued, basic for fiscal 2022 was 28.36M shares, a 1.89% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Issued, Basic 3 month | Weighted Average Number of Shares Issued, Basic 6 month | Weighted Average Number of Shares Issued, Basic 9 month | Weighted Average Number of Shares Issued, Basic 9 month as first filed | Weighted Average Number of Shares Issued, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 36.44M shares 10-Q · filed 2026-08-12 | 36.42M shares 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | 36.40M shares 10-Q · filed 2026-05-13 | ||||
| 2025-12-31 | 32.62M shares 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | 34.51M shares 10-Q · filed 2025-11-12 | 34.51M shares 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 30.10M shares 10-Q · filed 2026-08-12 | 30.07M shares 10-Q · filed 2026-08-12 | |||
| 2025-03-31 | 29.89M shares 10-Q · filed 2026-05-13 | ||||
| 2024-12-31 | 29.32M shares 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | 29.50M shares 10-Q · filed 2025-11-12 | 29.50M shares 10-Q · filed 2025-11-12 | 29.23M shares 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | 29.29M shares 10-Q · filed 2025-08-13 | 29.09M shares 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | 28.83M shares 10-Q · filed 2025-05-14 | ||||
| 2023-12-31 | 28.80M shares 10-K · filed 2025-03-26 | ||||
| 2023-09-30 | 28.81M shares 10-Q · filed 2024-11-12 | 28.79M shares 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 28.88M shares 10-Q · filed 2024-08-13 | 28.79M shares 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | 28.76M shares 10-Q · filed 2023-05-10 | ||||
| 2022-12-31 | 28.36M shares 10-K · filed 2023-03-29 | ||||
| 2022-09-30 | 28.39M shares 10-Q · filed 2022-11-10 | 28.30M shares 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | 28.26M shares 10-Q · filed 2022-08-10 | 28.26M shares 10-Q · filed 2022-08-10 | |||
| 2022-03-31 | 28.25M shares 10-Q · filed 2023-05-10 | ||||
| 2021-12-31 | 27.84M shares 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | 28.08M shares 10-Q · filed 2022-11-10 | 27.75M shares 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | 27.65M shares 10-Q · filed 2022-08-10 | 27.59M shares 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | 27.53M shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |